Lupin Ltd. Seeks Biosimilar, Lung Drug Partners

Indian drugmaker Lupin Ltd is seeking new partnership agreements as it moves into the promising fields of inhaled lung drugs and copies of biotechnology drugs, its managing director said. The United States and Japan were the most interesting regions for so-called "biosimilar" developments by Lupin and the company is actively seeking partners with the right drug development expertise, Nilesh Gupta told Reuters in an interview. Making copies of biotech medicines is emerging as a hot new business area for Indian pharmaceutical companies, which are seeking to move up the value curve by producing more complex and higher-margin generic products.

Help employers find you! Check out all the jobs and post your resume.